
54.63 BATS BZX Real-Time Price As of 1:54pm ET | ![]() Today’s Change | 42.51 Today|||52-Week Range 169.76 | -27.91% Year-to-Date |
The 22 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 117.00, with a high estimate of 220.00 and a low estimate of 52.00. The median estimate represents a +114.17% increase from the last price of 54.63.
The current consensus among 27 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.